Synovics Pharmaceuticals (SYVC) Stock Statistics & Valuation Metrics

Synovics Pharmaceuticals has a market cap or net worth of $2.98K. The enterprise value is ―.

Synovics Pharmaceuticals has 29,827,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Synovics Pharmaceuticals’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Synovics Pharmaceuticals is ―. Synovics Pharmaceuticals’s PEG ratio is ―.

In the last 12 months, Synovics Pharmaceuticals had revenue of ― and earned -4.01M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Synovics Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Synovics Pharmaceuticals upcoming earnings date is ―, ―.

Synovics Pharmaceuticals as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Synovics Pharmaceuticals has paid ― in taxes.

Synovics Pharmaceuticals EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Synovics Pharmaceuticals has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Synovics Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―